<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Illes-Toth E</submitter><funding>Biotechnology and Biological Sciences Research Council</funding><funding>Engineering and Physical Sciences Research Council</funding><pagination>e202202075</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9542108</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>61(36)</volume><pubmed_abstract>Here, we demonstrate detection by mass spectrometry of an intact protein-drug complex directly from liver tissue from rats that had been orally dosed with the drug. The protein-drug complex comprised fatty acid binding protein 1, FABP1, non-covalently bound to the small molecule therapeutic bezafibrate. Moreover, we demonstrate spatial mapping of the [FABP1+bezafibrate] complex across a thin section of liver by targeted mass spectrometry imaging. This work is the first demonstration of in situ mass spectrometry analysis of a non-covalent protein-drug complex formed in vivo and has implications for early stage drug discovery by providing a route to target-drug characterization directly from the physiological environment.</pubmed_abstract><journal>Angewandte Chemie (International ed. in English)</journal><pubmed_title>Mass Spectrometry Detection and Imaging of a Non-Covalent Protein-Drug Complex in Tissue from Orally Dosed Rats.</pubmed_title><pmcid>PMC9542108</pmcid><funding_grant_id>BB/S019456/1</funding_grant_id><funding_grant_id>EP/S002979/1</funding_grant_id><funding_grant_id>EP/R018367/1</funding_grant_id><pubmed_authors>Clayton B</pubmed_authors><pubmed_authors>Illes-Toth E</pubmed_authors><pubmed_authors>Rose J</pubmed_authors><pubmed_authors>Hughes JW</pubmed_authors><pubmed_authors>Dannhorn A</pubmed_authors><pubmed_authors>Cooper HJ</pubmed_authors><pubmed_authors>Strittmatter N</pubmed_authors><pubmed_authors>Hale OJ</pubmed_authors><pubmed_authors>Sargeant R</pubmed_authors><pubmed_authors>Jones S</pubmed_authors><pubmed_authors>Goodwin RJA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mass Spectrometry Detection and Imaging of a Non-Covalent Protein-Drug Complex in Tissue from Orally Dosed Rats.</name><description>Here, we demonstrate detection by mass spectrometry of an intact protein-drug complex directly from liver tissue from rats that had been orally dosed with the drug. The protein-drug complex comprised fatty acid binding protein 1, FABP1, non-covalently bound to the small molecule therapeutic bezafibrate. Moreover, we demonstrate spatial mapping of the [FABP1+bezafibrate] complex across a thin section of liver by targeted mass spectrometry imaging. This work is the first demonstration of in situ mass spectrometry analysis of a non-covalent protein-drug complex formed in vivo and has implications for early stage drug discovery by providing a route to target-drug characterization directly from the physiological environment.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-28T04:19:51.785Z</modification><creation>2024-11-15T00:43:39.188Z</creation></dates><accession>S-EPMC9542108</accession><cross_references><pubmed>35830332</pubmed><doi>10.1002/anie.202202075</doi></cross_references></HashMap>